SS
RGNX icon

SBI Securities’s Regenxbio RGNX Stock Holding History

SBI Securities’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.98K Buy
249
+5
+2% +$41 ﹤0.01% 2408
2026
Q1 		$2.04K Hold
244
– – ﹤0.01% 2415
2025
Q4 		$3.51K Buy
244
+4
+2% +$50 ﹤0.01% 2169
2025
Q3 		$2.32K Buy
240
+20
+9% +$177 ﹤0.01% 2366
2025
Q2 		$1.81K Buy
220
+1
+0.5% +$8 ﹤0.01% 2428
2025
Q1 		$1.57K Sell
219
-32
-13% -$238 ﹤0.01% 2399
2024
Q4 		$1.94K Buy
+251
New +$2.36K ﹤0.01% 2325

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

SBI Securities's RGNX Position: Q2 2026 in Review

SBI Securities increased its Regenxbio (RGNX) stake by 2% in Q2 2026, buying an estimated $41 and bringing the position to 249 shares worth $2.98K. The position accounts for ﹤0.01% of the portfolio, ranked #2408.

SBI Securities first reported a position in RGNX in Q4 2024 and has held it in 7 quarters since. The position peaked at $3.51K in Q4 2025. 165 funds tracked by Wall St. Rank hold RGNX as of Q2 2026.

  • SBI Securities held 249 shares of Regenxbio worth $2.98K as of Q2 2026.
  • SBI Securities bought 5 Regenxbio shares in Q2 2026, an estimated $41.
  • Regenxbio made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #2408 holding.
  • SBI Securities first reported a position in Regenxbio in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Regenxbio position peaked at $3.51K in Q4 2025.
  • 165 funds tracked by Wall St. Rank held Regenxbio as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.